Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

49 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share as of Q2 2018.
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9.01M shares of 266M outstanding shares and own 3.38% of the company stock.
Largest 10 shareholders include Woodford Investment Management Ltd (1.59M shares), Cormorant Asset Management, LP (1.53M shares), Capital World Investors (1.1M shares), Alphabet Inc. (714K shares), Artal Group S.A. (525K shares), PRICE T ROWE ASSOCIATES INC /MD/ (500K shares), FIL Ltd (433K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (250K shares), BAKER BROS. ADVISORS LP (235K shares), and Partner Fund Management, L.P. (198K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.